Related Experiment Video
Updated: Jun 25, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Inhibiting HSD17B8 suppresses the cell proliferation caused by PTEN failure
Wei Zhao1,2, Ruiting Huang1, Dongyang Ran1
1School of Basic Medical Sciences, Henan University, Kaifeng, Henan Province, China.
Abstract:
Loss of the tumor suppressor PTEN homolog daf-18 in Caenorhabditis elegans (C. elegans) triggers diapause cell division during L1 arrest. While prior studies have delved into established pathways, our investigation takes an innovative route. Through forward genetic screening in C. elegans, we pinpoint a new player, F12E12.11, regulated by daf-18, impacting cell proliferation independently of PTEN's typical phosphatase activity. F12E12.11 is an ortholog of human estradiol 17-beta-dehydrogenase 8 (HSD17B8), which converts estradiol to estrone through its NAD-dependent 17-beta-hydroxysteroid dehydrogenase activity. We found that PTEN engages in a physical interplay with HSD17B8, introducing a distinctive suppression mechanism. The reduction in estrone levels and accumulation of estradiol may arrest tumor cells in the G2/M phase of the cell cycle through MAPK/ERK. Our study illuminates an unconventional protein interplay, providing insights into how PTEN modulates tumor suppression by restraining cell division through intricate molecular interactions.
Insights
The tumor suppressor PTEN (phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase) interacts with HSD17B8, regulating cell division independently of PTEN
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- The tumor suppressor PTEN homolog daf-18 in C. elegans regulates cell division during L1 arrest.
- Established pathways involving PTEN's phosphatase activity are well-studied.
- A novel mechanism for PTEN-mediated cell cycle control is investigated.
Purpose of the Study:
- To identify novel regulators of cell proliferation controlled by daf-18.
- To elucidate the mechanism by which PTEN modulates cell division independently of its phosphatase activity.
- To explore a new protein-protein interaction involving PTEN in tumor suppression.
Main Methods:
- Forward genetic screening in Caenorhabditis elegans (C. elegans).
- Identification and characterization of the F12E12.11 gene and its protein product.
- Analysis of protein-protein interactions between daf-18 and F12E12.11.
- Investigation of the enzymatic activity of F12E12.11 (HSD17B8) and its effect on steroid hormone levels.
- Cell cycle analysis and pathway investigation (MAPK/ERK).
Main Results:
- A novel gene, F12E12.11, was identified as being regulated by daf-18 and impacting cell proliferation.
- F12E12.11 is the C. elegans ortholog of human estradiol 17-beta-dehydrogenase 8 (HSD17B8).
- PTEN physically interacts with HSD17B8, modulating its activity.
- This interaction leads to reduced estrone and increased estradiol levels.
- Estradiol accumulation may arrest tumor cells in G2/M phase via MAPK/ERK signaling.
Conclusions:
- PTEN restrains cell division through an unconventional interaction with HSD17B8, independent of its phosphatase activity.
- This interaction provides a novel mechanism for PTEN-mediated tumor suppression.
- The findings reveal intricate molecular interactions governing cell cycle control and tumor suppression.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

